readthroughSign in
CompanyFENCNasdaqResearch Triangle Park, NC

Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals develops PEDMARK, a medication to reduce platinum-induced ototoxicity in cancer patients receiving cisplatin-based chemotherapy.

SCHEDULE 13G/ANov 16Latest SEC filing
Sep 17Latest story